Stroke Treatment Academic Industry Roundtable (STAIR) Recommendations for Maximizing the Use of Intravenous Thrombolytics and Expanding Treatment Options With Intra-arterial and Neuroprotective Therapies
暂无分享,去创建一个
K. Furie | P. Gorelick | L. Goldstein | D. Liebeskind | J. Saver | G. Albers | R. Nogueira | L. Wechsler | D. Hess | Patty Hurn
[1] P. Davis,et al. Cooling for newborns with hypoxic ischaemic encephalopathy. , 2013, The Cochrane database of systematic reviews.
[2] H. Diener,et al. Influence of Age on Outcome From Thrombolysis in Acute Stroke: A Controlled Comparison in Patients From the Virtual International Stroke Trials Archive (VISTA) , 2010, Stroke.
[3] M. Kaste,et al. Comparison of Outcomes Following Thrombolytic Therapy Among Patients With Prior Stroke and Diabetes in the Virtual International Stroke Trials Archive (VISTA) , 2010, Diabetes Care.
[4] L. Svensson,et al. Intra-Arrest Transnasal Evaporative Cooling: A Randomized, Prehospital, Multicenter Study (PRINCE Pre-ROSC IntraNasal Cooling Effectiveness) , 2010, Circulation.
[5] M. Kaste,et al. Off-Label Thrombolysis Is Not Associated With Poor Outcome in Patients With Stroke , 2010, Stroke.
[6] Ann P Rafferty,et al. Lack of Association Between Stroke Symptom Knowledge and Intent to Call 911: A Population-Based Survey , 2010, Stroke.
[7] Rema Raman,et al. Stroke Team Remote Evaluation Using a Digital Observation Camera in Arizona: The Initial Mayo Clinic Experience Trial , 2010, Stroke.
[8] K. Furie,et al. Conscious Sedation Versus General Anesthesia During Endovascular Therapy for Acute Anterior Circulation Stroke: Preliminary Results From a Retrospective, Multicenter Study , 2011 .
[9] Gregory W Albers,et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials , 2010, The Lancet.
[10] L. Goldstein,et al. Hospital Arrival Time and Intravenous t-PA Use in US Academic Medical Centers, 2001–2004 , 2009, Stroke.
[11] Wade S. Smith,et al. Predictors of Good Clinical Outcomes, Mortality, and Successful Revascularization in Patients With Acute Ischemic Stroke Undergoing Thrombectomy: Pooled Analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials , 2009, Stroke.
[12] J. Broderick,et al. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent , 2009, Neurology.
[13] Jeffrey L Saver,et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. , 2009, Stroke.
[14] Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: Safety and Effectiveness of a New Generation of Mechanical Devices for Clot Removal in Intracranial Large Vessel Occlusive Disease , 2009, Stroke.
[15] Marc Fisher,et al. Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations , 2009, Stroke.
[16] Q. Shah,et al. Super-Selective Intra-arterial Magnesium Sulfate in Combination With Nicardipine for the Treatment of Cerebral Vasospasm in Patients With Subarachnoid Hemorrhage , 2009, Neurocritical care.
[17] A. Gunn,et al. Does Head Cooling With Mild Systemic Hypothermia Affect Requirement for Blood Pressure Support? , 2009, Pediatrics.
[18] L. Steinman,et al. Systems biology and its application to the understanding of neurological diseases , 2009, Annals of neurology.
[19] M. Kaste,et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.
[20] M. Luby,et al. Acute Stroke Imaging Research Roadmap II , 2008, Stroke.
[21] Geoffrey A. Donnan,et al. Acute Stroke Imaging Research Roadmap , 2008, Stroke.
[22] Joseph P Broderick,et al. National US Estimates of Recombinant Tissue Plasminogen Activator Use: ICD-9 Codes Substantially Underestimate , 2008, Stroke.
[23] G. Steinberg,et al. Limb remote-preconditioning protects against focal ischemia in rats and contradicts the dogma of therapeutic time windows for preconditioning , 2008, Neuroscience.
[24] Adnan I. Qureshi,et al. Guidelines for the Early Management of Adults With Ischemic Stroke , 2007 .
[25] S. Warach,et al. Recommendations from the STAIR V meeting on acute stroke trials, technology and outcomes. , 2007, Stroke.
[26] J. Broderick,et al. Intracranial Hemorrhage Associated With Revascularization Therapies , 2007, Stroke.
[27] R. Sacco,et al. Quality improvement in acute stroke , 2006, Neurology.
[28] Eric E. Smith,et al. Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke , 2005, Stroke.
[29] Jane C Khoury,et al. Revascularization End Points in Stroke Interventional Trials: Recanalization Versus Reperfusion in IMS-I , 2005, Stroke.
[30] H. Lutsep,et al. Safety and Efficacy of Mechanical Embolectomy in Acute Ischemic Stroke: Results of the MERCI Trial , 2005, Stroke.
[31] Jeffrey L. Saver,et al. Prehospital Neuroprotective Therapy for Acute Stroke: Results of the Field Administration of Stroke Therapy–Magnesium (FAST–MAG) Pilot Trial , 2004, Stroke.
[32] J. Alger,et al. Beyond Mismatch: Evolving Paradigms in Imaging the Ischemic Penumbra With Multimodal Magnetic Resonance Imaging , 2003, Stroke.
[33] E. Kanal,et al. The Cortical Ischemic Core and Not the Consistently Present Penumbra Is a Determinant of Clinical Outcome in Acute Middle Cerebral Artery Occlusion , 2003, Stroke.
[34] U. Dirnagl,et al. Stroke-induced Immunodeficiency Promotes Spontaneous Bacterial Infections and Is Mediated by Sympathetic Activation Reversal by Poststroke T Helper Cell Type 1–like Immunostimulation , 2003, The Journal of experimental medicine.
[35] H. Diener,et al. European Stroke Initiative Recommendations for Stroke Management – Update 2003 , 2003, Cerebrovascular Diseases.
[36] Alan D. Lopez,et al. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. , 2002, The New England journal of medicine.
[37] Michael Holzer,et al. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest , 2002 .
[38] A. Demchuk,et al. Why are stroke patients excluded from TPA therapy? , 2001, Neurology.
[39] G. Hankey,et al. European Stroke Initiative Recommendations for Stroke Management , 2000, Cerebrovascular Diseases.
[40] P. Akins,et al. Intra-arterial prourokinase for acute ischemic stroke. , 2000, JAMA.
[41] R. Higashida,et al. Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial , 1999 .
[42] M. Moskowitz,et al. Pathobiology of ischaemic stroke: an integrated view , 1999, Trends in Neurosciences.
[43] H. Ellis. stroke , 1997, The Lancet.
[44] V Larrue,et al. Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. , 1997, Stroke.
[45] P. Duncan,et al. Health status of individuals with mild stroke. , 1997, Stroke.
[46] A. Furlan. Clot retrieval for stroke should be restricted to clinical trials: no. , 2010, Stroke.